Stock EXACTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Exactech, Inc.

Equities

US30064E1091

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Exactech : Announces Completion of Merger with TPG Capital
BU
Exactech : Shareholders Approve Merger Agreement with TPG Capital
BU
Exactech : Announces Successful First Surgery with Vantage ® Total Ankle Mobile Bearing System
BU
Exactech : and TPG Capital Announce Amended Merger Agreement Providing for Increase in Merger Consideration to $49.25 per share
BU
Exactech : Announces Successful First Revision Knee Replacement Surgery with Truliant® Instrumentation
BU
Brower Piven Commences an Investigation into the Proposed Sale of Exactech, Inc. and Encourages Shareholders to Contact the Firm for Additional Information
BU
Exactech : Q3 Revenue $61.4 Million
BU
Brower Piven Commences An Investigation Into The Proposed Sale Of Exactech, Inc. And Encourages Investors To Contact The Firm For Additional Information
BU
EXACTECH INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Exactech, Inc.
PR
Bragar Eagel & Squire, P.C. : is Investigating the Board of Directors of Exactech (EXAC) on Behalf of Stockholders and Encourages Investors to Contact the Firm
BU
Exactech : Cancels Q3 Earnings Call Previously Scheduled for Tuesday, October 31, 2017
BU
WEISSLAW LLP: Exactech, Inc. Acquisition May Not Be in the Best Interests of EXAC Shareholders
PR
Exactech : Enters Definitive Agreement with TPG Capital to Go Private
BU
Exactech : Comments on Impact of Hurricanes Irma and Harvey; Adjusts Q3 Earnings Guidance and Announces Q3 Earnings Call
BU
Exactech : To Present to Investors at Baird 2017 Global Healthcare Conference
BU
Exactech :’s Truliant® Knee System Instrumentation Honored with International Design Excellence Award (IDEA®)
BU
Exactech : Q2 Revenue $67.3 Million On Continuing Strong Extremities Revenue; Q2 Net Income $4.8 Million; Diluted EPS $0.33
PU
Exactech : Q2 Revenue $67.3 Million On Continuing Strong Extremities Revenue
BU
Exactech : Schedules Second Quarter 2017 Earnings Release and Conference Call
BU
Exactech : Introduces New Computer-Assisted Software Application for Simplified Guidance in Total Knee Replacement
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News Exactech, Inc.